DiogenX
ID: 7687418DiogenX is a regenerative diabetes treatment founded in 2019 by Jean-Pascal Tranié, Benjamin Charles and Patrick Collombat.
2
Funding Rounds
$35.1m
Money raised
Recent Funding Rounds
Overview
DiogenX is a regenerative diabetes treatment founded in 2019 by Jean-Pascal Tranié, Benjamin Charles and Patrick Collombat.
- Website:
- Business model: B2C
- Headquarters: Marseille
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Je********* Tr***** |
|
- | - |
| Be****** Ch***** |
|
- | |
| Pa***** Co******* |
|
- |
Funding
Funding series
Funding Series Analysis
The company DiogenX has raised a total of $35.1m in funding over 2 rounds.
Key Insights:
- DiogenX May 2023 Series A Funding Round: $30m
- DiogenX Seed round, June 2020: $5.1m
Industries
DiogenX is active in the following industries: